Pharmaceuticals

Industry Overview

With global demographic changes, a changing healthcare focus, and the cost pressures driven by the healthcare reform, the challenges facing the pharmaceutical industry are daunting. These social and economic shifts are creating some unprecedented trends, possibly reshaping the industry for the foreseeable future.

The US pharmaceutical industry is a highly globalized industry, dominated by multinational companies that engage in significant business activity in many countries and whose products are distributed and marketed worldwide. The industry has undergone dramatic structural changes over the past few decades, with the rise of the biotechnology sector, substantial growth in demand driven by demographics and substitution away from other therapeutic modalities such as surgery, and increased competition from globally active generic manufacturers. 

China – The growth was mainly fueled by rising annual disposable incomes, expanding middle-class populations and growing incidence of chronic diseases. Prevention is now center stage as a way to possibly reduce longer term spending on healthcare. The aging population will also play into prevention, as there is greater focus on this rapidly expanding segment of the population. This prevention will in-turn lead to a greater emphasis on vaccines.

Priority Metrics Group conducts custom market research and provides unparalleled insight needed for uncovering growth opportunities in the pharmaceutical and related healthcare markets.